These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25158967)
1. Application of micellar liquid chromatography for the determination of antitumoral and antiretroviral drugs in plasma. Peris-Vicente J; Casas-Breva I; Roca-Genovés P; Esteve-Romero J Bioanalysis; 2014; 6(14):1975-88. PubMed ID: 25158967 [TBL] [Abstract][Full Text] [Related]
2. A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasma. Peris-Vicente J; Villareal-Traver M; Casas-Breva I; Carda-Broch S; Esteve-Romero J J Pharm Biomed Anal; 2014 Sep; 98():351-5. PubMed ID: 24996008 [TBL] [Abstract][Full Text] [Related]
3. A review on development of analytical methods to determine monitorable drugs in serum and urine by micellar liquid chromatography using direct injection. Esteve-Romero J; Albiol-Chiva J; Peris-Vicente J Anal Chim Acta; 2016 Jul; 926():1-16. PubMed ID: 27216388 [TBL] [Abstract][Full Text] [Related]
4. Use of micellar liquid chromatography to analyze darunavir, ritonavir, emtricitabine, and tenofovir in plasma. Peris-Vicente J; Villarreal-Traver M; Casas-Breva I; Carda-Broch S; Esteve-Romero J J Sep Sci; 2014 Oct; 37(20):2825-32. PubMed ID: 25103282 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a micellar liquid chromatographic method to determine three antitumorals in plasma. Romero JE; Chiva JA; Peris-Vicente J; Ochoa-Aranda E Bioanalysis; 2017 May; 9(10):799-812. PubMed ID: 28520456 [TBL] [Abstract][Full Text] [Related]
6. Development of a method to determine axitinib, lapatinib and afatinib in plasma by micellar liquid chromatography and validation by the European Medicines Agency guidelines. Albiol-Chiva J; Esteve-Romero J; Peris-Vicente J J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():61-69. PubMed ID: 29331859 [TBL] [Abstract][Full Text] [Related]
7. [Micellar liquid chromatography and its application in toxicological analysis]. Cheng XW; Jiang WH; Chu JX Fa Yi Xue Za Zhi; 2010 Feb; 26(1):56-8, 63. PubMed ID: 20232747 [TBL] [Abstract][Full Text] [Related]
8. A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines. Garrido-Cano I; García-García A; Peris-Vicente J; Ochoa-Aranda E; Esteve-Romero J Talanta; 2015 Nov; 144():1287-95. PubMed ID: 26452960 [TBL] [Abstract][Full Text] [Related]
10. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs. Taylor PJ; Tai CH; Franklin ME; Pillans PI Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma. Bobin-Dubigeon C; Amiand MB; Herrenknecht C; Bard JM J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2451-6. PubMed ID: 19560408 [TBL] [Abstract][Full Text] [Related]
12. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines. Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950 [TBL] [Abstract][Full Text] [Related]
13. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography. Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137 [TBL] [Abstract][Full Text] [Related]
14. Direct plasma metabolite analysis of positron emission tomography radioligands by micellar liquid chromatography with radiometric detection. Nakao R; Schou M; Halldin C Anal Chem; 2012 Apr; 84(7):3222-30. PubMed ID: 22409870 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. Casas-Breva I; Peris-Vicente J; Rambla-Alegre M; Carda-Broch S; Esteve-Romero J Analyst; 2012 Sep; 137(18):4327-34. PubMed ID: 22858583 [TBL] [Abstract][Full Text] [Related]
17. Retention mechanism and implications for selectivity for a group of dihydropyridines in ionic micellar liquid chromatography. Saz JM; Marina ML J Chromatogr A; 1994 Dec; 687(1):1-12. PubMed ID: 7849985 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Jung BH; Rezk NL; Bridges AS; Corbett AH; Kashuba AD Biomed Chromatogr; 2007 Oct; 21(10):1095-104. PubMed ID: 17582235 [TBL] [Abstract][Full Text] [Related]
19. Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine. Nageswara Rao R; Shinde DD J Pharm Biomed Anal; 2009 Dec; 50(5):994-9. PubMed ID: 19729260 [TBL] [Abstract][Full Text] [Related]
20. "Mixed" anionic and non-ionic micellar liquid chromatography for high-speed radiometabolite analysis of positron emission tomography radioligands. Nakao R; Halldin C J Chromatogr A; 2013 Mar; 1281():54-9. PubMed ID: 23399000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]